Wednesday, October 8, 2025

16:15 - 17:00

RAMÓN Y CAJAL ROOM

---

Overview

Sponsor: BME

---

Details

Artificial Intelligence is redefining the landscape of life sciences investment — from deal sourcing and risk assessment to portfolio management and capital market strategies. This roundtable will explore how data-driven decision-making and AI-powered analytics are transforming the financial ecosystem supporting biotech and healthcare innovation. Leading voices from venture capital, financial markets, and corporate governance will share real-world insights into how AI tools are being implemented to enhance efficiency, transparency, and strategic foresight in investment processes. The discussion will also address the challenges of adopting these technologies — from data reliability and ethical implications to regulatory frameworks and human oversight.

---

Details